Injective adds native USDC and CCTP, enabling direct cross-chain transfers, improving liquidity, and reducing reliance on bridges.
Circle (CRCL) stock rises 2.83% as USDC launches natively on Injective with CCTP support, enabling secure crosschain transfers and enhanced liquidity.
Cross-Chain Compatibility: Injective Protocol is designed to be cross-chain compatible, allowing users to trade assets from different blockchain networks seamlessly. This interoperability expands the ...
After the pain of 2022, last year was encouraging for the broader crypto community. Bitcoin (BTC), Solana (SOL), and Injective Protocol (INJ) rallied, drawing billions to the industry. Injective ...
Injective will support native USDC issuance and integrate Circle’s CCTP for direct cross-chain stablecoin transfers.
Holdings include 7.20 million Injective tokens, $5.00 million stablecoin holdings, and $15.79 million in cash INJ protocol upgrade doubles the rate of token deflation, enhancing INJ as treasury asset ...
T-Bill-backed USDM will be available on Injective, with Helix as the first dApp to support both spot and derivatives trading. The introduction of USDM is a significant addition to real-world assets ...
Injective Protocol, an Ethereum-compatible blockchain used in decentralized finance (DeFi) and derivatives industries, underwent a "CosmWasm mainnet" upgrade in early in July in order to provide ...
Injective Labs announced Wednesday that it will integrate Wormhole, a message-passing protocol, into the Injective ecosystem. The integration will allow decentralized applications (dApps) in the ...
Injective Protocol (INJ-USD) stock price is 3.06 and Injective Protocol (INJ-USD) 10-day simple moving average is 3.32. Injective Protocol (INJ-USD) stock price is 3.06 and Injective Protocol (INJ-USD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results